We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Division of Preventive Oncology

Prof. Dr. Hermann Brenner (in ch.)

Prof. Hermann Brenner, head of the DKFZ Division of Clinical Epidemiology and Aging Research, has been serving as acting head of the Preventive Oncology Division since 2014.
Under his leadership, a research program in the field of secondary prevention has been implemented focusing on enhanced screening strategies for early detection of cancer and cancer prevention.
In 2016 two new studies were launched: The Gekko study (starting in January 2016) and the DARIO study (starting in June 2016). In 2020 the LEO study was launched, a large-scale scientific study conducted by the Preventive Oncology Division at the National Center for Tumor Diseases (NCT) Heidelberg together with the Interdisciplinary Endoscopy Centre Heidelberg. Since the start of the LEO study, the preventive oncology team has recruited participants from the age group 30-49 based on the NCT "Proof of Concept Trial".
Another focus under development is risk-adapted prevention, a work group under the leadership of Prof. Mahdi Fallah.

Contact

Prof. Dr. Hermann Brenner (in ch.)

Preventive Oncology (C120)

Deutsches Krebsforschungszentrum

Im Neuenheimer Feld 581

69120 Heidelberg

Tel: +49 6221 42 1300

E-Mail:
h.brenner@dkfz.de
angelika.bergmann@nct-heidelberg.de

Selected Publications

Raut J.R. et al (2021). A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction. Nat Commun. 12(1), 4811.
Tian Y. et al. (2019). Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study. BMJ 364:l803.
Gies A. et al. (2018) Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening. Gastroenterology 154(1):93-104.
Brenner H. et al. (2014). Colorectal cancer. Lancet, 383(9927), 1490-1502.